“Haste this process is complete, we recommend this break”, dijo.
According to the joint statement of the FDA and the Centers for Control and Prevention of Injuries (CDC, by its rules in English) “” these events appear extremely rare and recommend temporary cancellation for precaution “.
The regulator informs that the moon has been administered more than 6.8 million doses of the Johnson & Johnson vaccine in United States.
“The FDA’s CDC is reviewing data from 6 cases reported in the United States of a rare blood type and only produced and individuals able to receive the vaccine. At present, these adverse events appear to be extremely rare,” the FDA wrote. of Twitter.
Six cases will occur in women between 18 and 48 years of age that develop symptoms between six and 13 days after receiving the injection.
People who are waking up during a period of up to three weeks develop intense cabbage pain, abdominal pain, pain in the paws or difficulty breathing, need to communicate with their medicine doctor, ”recommends the FDA and the CDC.
“The safety of the COVID-19 vaccine is one of the principal priorities of the federal government and we will take very seriously all information related to posterior health problems with the vaccination against the virus,” the federal agencies said in a statement.
The agency affirms that pide is an interruption to allow the medical attention providers to obtain “the only treatment required against this type of song coagulation”.
The CDC will convene a committee to assess the markets “to review more of these cases and evaluate their potential imports. The FDA is reviewing this analysis and also investigating these cases”.
The statement was made after the European Union’s drug regulator said it was also reviewing possible cases of blood clots in people receiving Johnson & Johnson’s injection.